These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25297782)

  • 1. [Risk of transfusion-transmitted infection in Japan].
    Satake M
    Rinsho Ketsueki; 2014 Oct; 55(10):2152-61. PubMed ID: 25297782
    [No Abstract]   [Full Text] [Related]  

  • 2. Major risk of blood transfusion in hemolytic anemia patients.
    Omar N; Salama K; Adolf S; El-Saeed GS; Abdel Ghaffar N; Ezzat N
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):280-4. PubMed ID: 21508832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-transmitted viruses.
    Wright-Kanuth MS; Smith LA
    Clin Lab Sci; 2003; 16(4):221-9. PubMed ID: 14626440
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sexually transmitted liver diseases: infection risk and prevention possibilities].
    Baumgarten R
    Wien Med Wochenschr; 1997; 147(19-20):443-4. PubMed ID: 9471840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current issues in blood component therapy: transmission of infectious diseases.
    Menitove JE
    Oncology (Williston Park); 1987 Jun; 1(4):21-30. PubMed ID: 2856350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual risk of transfusion transmitted viral infections among seronegative donors: application of the incidence/window period model.
    Kleinman S
    Dev Biol (Basel); 2000; 102():61-5. PubMed ID: 10794091
    [No Abstract]   [Full Text] [Related]  

  • 7. Transfusion-transmitted diseases: current problems and challenges.
    Bove JR
    Prog Hematol; 1986; 14():123-47. PubMed ID: 3003795
    [No Abstract]   [Full Text] [Related]  

  • 8. [Post-transfusion viral hepatitis].
    Katayama T
    Rinsho Byori; 1991 Mar; Suppl 88():156-70. PubMed ID: 1906949
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatitis and pregnancy--a short review].
    Zygmunt M
    Z Geburtshilfe Neonatol; 2003; 207(4):153-6. PubMed ID: 14528419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR; Kiely P; Keller AJ
    Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of non-A, non-B hepatitis, cytomegalovirus and the acquired immune deficiency syndrome in transfusion practice.
    Bayer WL; Tegtmeier GE; Barbara JA
    Clin Haematol; 1984 Feb; 13(1):253-69. PubMed ID: 6327132
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century.
    Dwyre DM; Fernando LP; Holland PV
    Vox Sang; 2011 Jan; 100(1):92-8. PubMed ID: 21175659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk of infection in hemotherapy].
    Sibrowski W; Wüllenweber J
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():60-3. PubMed ID: 8000255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The problem of post-transfusion hepatitis].
    Sugg M
    Beitr Infusionther Klin Ernahr; 1986; 15():30-8. PubMed ID: 3019299
    [No Abstract]   [Full Text] [Related]  

  • 15. [Present status of transfusion-associated hepatitis C virus infection--efficiency after implementation of nucleic acid amplification testing].
    Takahashi M; Muraoka M; Tadokoro K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):267-71. PubMed ID: 15359805
    [No Abstract]   [Full Text] [Related]  

  • 16. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral infections transmitted by blood and its products.
    Barbara JA; Tedder RS
    Clin Haematol; 1984 Oct; 13(3):693-707. PubMed ID: 6094064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low-endemic region.
    Stolz M; Tinguely C; Graziani M; Fontana S; Gowland P; Buser A; Michel M; Canellini G; Züger M; Schumacher P; Lelie N; Niederhauser C
    Transfusion; 2010 Dec; 50(12):2695-706. PubMed ID: 20573074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National strategy for the prevention and management of transfusion-associated hepatitis.
    Voigt MD; Bird AR; Kirsch RE; Kew MC; Aspinall S; Sims J
    S Afr Med J; 1996 Mar; 86(3):245-51. PubMed ID: 8658294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.